Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Billions.
The item "Diluted-Average-Shares" stands at 9.70 Billion for the trailing twelve months (TTM) period ending 09/30/2025.
Johnson & Johnson's third quarter result of 2.43 Billion for the item "Diluted Average Shares" represents an increase of 0.39 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 2.43 Billion for the item "Diluted Average Shares" represents an increase of 0.03 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 9.70 Billion for the item "Diluted Average Shares" represents an increase of 0.01 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.1246 percent compared to the value the year prior.
The 1 year change in percent is -0.1246.
The 3 year change in percent is -9.07.
The 5 year change in percent is -9.15.
The 10 year change in percent is -14.10.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted Average Shares | 905,699,262,464.00 |
![]() | AbbVie Inc - Diluted Average Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted Average Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted Average Shares | 280,205,508,085.11 |
![]() | Novartis AG - Diluted Average Shares | 255,096,620,580.91 |